Marion Scharpfenecker

Lead Minimally Invasive Techniques at KWF Kankerbestrijding

Marion Scharpfenecker is an experienced professional in the field of medical research, currently serving as Clusterlead for Early Detection and Minimally Invasive Techniques at KWF Kankerbestrijding since January 2018. Responsibilities include facilitating research projects, managing relationships with stakeholders, and leading various significant programs related to cancer research and biomarker development. Concurrently, Marion holds positions as Guest Researcher and Assistant Professor at Leiden University Medical Center, focusing on vascular and immunopathology in kidney diseases. Marion's previous roles include senior postdoctoral research on radiation toxicity at Antoni van Leeuwenhoek and postdoctoral research on angiogenesis and microvascular injury. Educational background includes a degree in Biology from the University of Hohenheim.

Location

The Hague, Netherlands

Links

Previous companies


Org chart

No direct reports

Teams


Offices


KWF Kankerbestrijding

Every person in the Netherlands will at some stage have an experience with cancer When you have cancer, it disrupts your life, but also when someone you know has the disease. The consequences are overwhelming. To all those millions of lives, every day we can make the difference, successfully, for more than 71 years. We not only fight this disease, but we also strive for a better life living with cancer. We work on life-changing research and make sure that expensive medicines are available quickly to everyone. From approachable open houses to the safe community kanker.nl making sure we can support everyone who is living with cancer. And by mobilising the whole of the Netherlands for our joint mission. To make sure fewer people get cancer, more people are cured and more people live better with and after cancer. Simply because there’s so much to live for. DCS. Against cancer. For life.


Employees

51-200

Links